[Down syndrome screening by ultrasound]
- PMID: 16005667
- DOI: 10.1016/j.gyobfe.2005.05.021
[Down syndrome screening by ultrasound]
Abstract
The nuchal translucency is the usual subcutaneous space, between the skin and the soft tissues covering the fetus'neck spine, observed by ultrasound during the first trimester of pregnancy. It increases with gestational age. The association between nuchal translucency thickness and risk of Down syndrome was firstly observed in high risk populations as an old maternal age or a history of a previous child affected by Down syndrome. However, these studies are retrospective and only report the issue among pregnancies associated with an abnormal nuchal translucency thickness. Furthermore, as the performance of a screening test is correlated to the prevalence of the disease in the studied population, such results can not be extrapolated to the general population. To date, eleven prospective studies have been published, assessing the performance of the nuchal translucency measurement in a general population, including about 125,000 patients. The global sensitivity of this screening was 70% for a false positive rate of 5%. For an adjusted risk on the maternal age, the detection rate increased up to 77%. Although nuchal translucency measurement is an early and performing screening tool, uncertainties remain nevertheless about its reproducibility in the general population. In order to correctly measure the nuchal translucency, a previous training course is necessary to guarantee adequate and reproducible measurements.
Similar articles
-
Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.Ultrasound Obstet Gynecol. 2001 Jul;18(1):26-31. doi: 10.1046/j.1469-0705.2001.00457.x. Ultrasound Obstet Gynecol. 2001. PMID: 11489221
-
Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.Ultrasound Obstet Gynecol. 1998 Sep;12(3):163-9. doi: 10.1046/j.1469-0705.1998.12030163.x. Ultrasound Obstet Gynecol. 1998. PMID: 9793187 Clinical Trial.
-
Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.Ultrasound Obstet Gynecol. 1998 Sep;12(3):156-62. doi: 10.1046/j.1469-0705.1998.12030156.x. Ultrasound Obstet Gynecol. 1998. PMID: 9793186 Clinical Trial.
-
Nuchal translucency-based Down syndrome screening: barriers to implementation.Semin Perinatol. 2005 Aug;29(4):272-6. doi: 10.1053/j.semperi.2005.05.002. Semin Perinatol. 2005. PMID: 16104681 Review.
-
[Screening for trisomy 21 by measuring nuchal translucency during the first trimester of pregnancy].J Gynecol Obstet Biol Reprod (Paris). 1997;26(7):671-8. J Gynecol Obstet Biol Reprod (Paris). 1997. PMID: 9471429 Review. French.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical